592 related articles for article (PubMed ID: 32316223)
1. CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review.
Syding LA; Nickl P; Kasparek P; Sedlacek R
Cells; 2020 Apr; 9(4):. PubMed ID: 32316223
[TBL] [Abstract][Full Text] [Related]
2. Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies.
Hiura H; Okae H; Miyauchi N; Sato F; Sato A; Van De Pette M; John RM; Kagami M; Nakai K; Soejima H; Ogata T; Arima T
Hum Reprod; 2012 Aug; 27(8):2541-8. PubMed ID: 22674207
[TBL] [Abstract][Full Text] [Related]
3. Prader-Willi Syndrome: Molecular Mechanism and Epigenetic Therapy.
Mian-Ling Z; Yun-Qi C; Chao-Chun Z
Curr Gene Ther; 2020; 20(1):36-43. PubMed ID: 32329685
[TBL] [Abstract][Full Text] [Related]
4. Allele-Specific Epigenome Editing.
Bashtrykov P; Jeltsch A
Methods Mol Biol; 2018; 1767():137-146. PubMed ID: 29524132
[TBL] [Abstract][Full Text] [Related]
5. Association of four imprinting disorders and ART.
Hattori H; Hiura H; Kitamura A; Miyauchi N; Kobayashi N; Takahashi S; Okae H; Kyono K; Kagami M; Ogata T; Arima T
Clin Epigenetics; 2019 Feb; 11(1):21. PubMed ID: 30732658
[TBL] [Abstract][Full Text] [Related]
6. Correction of aberrant imprinting by allele-specific epigenome editing.
Bashtrykov P; Kungulovski G; Jeltsch A
Clin Pharmacol Ther; 2016 May; 99(5):482-4. PubMed ID: 26537177
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
8. Successful generation of epigenetic disease model mice by targeted demethylation of the epigenome.
Horii T; Morita S; Hino S; Kimura M; Hino Y; Kogo H; Nakao M; Hatada I
Genome Biol; 2020 Apr; 21(1):77. PubMed ID: 32234052
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas mediated epigenome editing for cancer therapy.
Ansari I; Chaturvedi A; Chitkara D; Singh S
Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
[TBL] [Abstract][Full Text] [Related]
10. Human imprinting syndromes.
Lim DH; Maher ER
Epigenomics; 2009 Dec; 1(2):347-69. PubMed ID: 22122706
[TBL] [Abstract][Full Text] [Related]
11. Prader-Willi and Angelman syndromes. Disorders of genomic imprinting.
Cassidy SB; Schwartz S
Medicine (Baltimore); 1998 Mar; 77(2):140-51. PubMed ID: 9556704
[TBL] [Abstract][Full Text] [Related]
12. Clinical Validation of a Genome-Wide DNA Methylation Assay for Molecular Diagnosis of Imprinting Disorders.
Aref-Eshghi E; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Siu V; Rodenhiser D; Schwartz C; Sadikovic B
J Mol Diagn; 2017 Nov; 19(6):848-856. PubMed ID: 28807811
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.
Maroufi F; Maali A; Abdollahpour-Alitappeh M; Ahmadi MH; Azad M
Epigenomics; 2020 Oct; 12(20):1845-1859. PubMed ID: 33185489
[TBL] [Abstract][Full Text] [Related]
14. Genomic imprinting disorders in humans: a mini-review.
Butler MG
J Assist Reprod Genet; 2009; 26(9-10):477-86. PubMed ID: 19844787
[TBL] [Abstract][Full Text] [Related]
15. Potential of Epigenetic Therapy for Prader-Willi Syndrome.
Wang SE; Jiang YH
Trends Pharmacol Sci; 2019 Sep; 40(9):605-608. PubMed ID: 31353046
[TBL] [Abstract][Full Text] [Related]
16. Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes.
Glenn CC; Driscoll DJ; Yang TP; Nicholls RD
Mol Hum Reprod; 1997 Apr; 3(4):321-32. PubMed ID: 9237260
[TBL] [Abstract][Full Text] [Related]
17. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
Pei WD; Zhang Y; Yin TL; Yu Y
Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
[TBL] [Abstract][Full Text] [Related]
18. Epigenome Editing in the Brain.
Bashtrykov P; Jeltsch A
Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
[TBL] [Abstract][Full Text] [Related]
19. Concurrent genome and epigenome editing by CRISPR-mediated sequence replacement.
Alexander J; Findlay GM; Kircher M; Shendure J
BMC Biol; 2019 Nov; 17(1):90. PubMed ID: 31739790
[TBL] [Abstract][Full Text] [Related]
20. Angelman syndrome imprinting center encodes a transcriptional promoter.
Lewis MW; Brant JO; Kramer JM; Moss JI; Yang TP; Hansen PJ; Williams RS; Resnick JL
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6871-5. PubMed ID: 25378697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
